# Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

> **NCT02313688** · NA · UNKNOWN · sponsor: **West China Hospital** · enrollment: 320 (estimated)

## Conditions studied

- Stomach Neoplasms
- Siewert Type II Adenocarcinoma of Esophagogastric Junction
- Recurrence
- Siewert Type III Adenocarcinoma of Esophagogastric Junction

## Interventions

- **PROCEDURE:** gastrectomy
- **PROCEDURE:** gastrectomy

## Key facts

- **NCT ID:** NCT02313688
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2020-12
- **Final completion:** 2023-12
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313688, "Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02313688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*